DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Sierra Oncology Q4 EPS $(2.51) Beats $(3.16) Estimate

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(2.51) per share which beat the analyst consensus estimate of $(3.16) by 20.57 percent. This is a 1221.05 percent decrease over losses of $(0.19) per share from

Benzinga · 03/03/2020 12:13

Sierra Oncology (NASDAQ:SRRA) reported quarterly losses of $(2.51) per share which beat the analyst consensus estimate of $(3.16) by 20.57 percent. This is a 1221.05 percent decrease over losses of $(0.19) per share from the same period last year.